Spina Bifida & Muscle Wasting: Neurogenic Atrophy Mechanisms

Muscle wasting (neurogenic atrophy) is a hallmark of spina bifida, directly resulting from lower motor neuron disruption.

Pathophysiology

  • Neural tube defect: Incomplete closure → exposed/damaged spinal cord segments.
  • Lower motor neuron loss: Anterior horn cells at affected levels degenerate.
  • Denervation: Muscle fibers lose trophic input → atrophy, fibrillations, fasciculations.
  • Level correspondence: Lumbar/sacral segments → lower extremity wasting (L2–S1 myotomes).

Clinical Patterns by Level

Neurologic LevelMuscle Groups AffectedFunctional Impact
ThoracicTrunk control, respiratoryParaplegia, scoliosis risk
L2–L3Hip flexors, knee extensorsAmbulation with KAFOs/crutches
L4–L5Ankle dorsiflexors, invertorsFoot drop; AFOs often sufficient
S1–S2Plantar flexors, glutealsPush-off weakness; community ambulation
S3–S5Bladder/bowel sphinctersNeurogenic bowel/bladder

Management Strategies

  • Early PT/OT: Prevent contractures, maximize function, orthotic prescription.
  • FES (functional electrical stimulation): Maintains muscle bulk, improves circulation.
  • Surgical: Tendon transfers, osteotomies, hip reconstruction.
  • Spasticity management: Baclofen, botulinum toxin, SDR (selective dorsal rhizotomy).
  • Bone health: Weight-bearing, vitamin D, bisphosphonates if osteoporotic.

Multidisciplinary Care

Spina bifida clinics (neurosurgery, orthopedics, urology, PT/OT, neuropsychology) improve longevity and quality of life. Transition to adult care critical.

Muscle Strains - Related Articles